HDAC inhibitors: roles of DNA damage and repair.
暂无分享,去创建一个
[1] P. Jeggo,et al. The C Terminus of Ku80 Activates the DNA-Dependent Protein Kinase Catalytic Subunit , 1999, Molecular and Cellular Biology.
[2] Stephen P. Jackson,et al. Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair*S⃞ , 2009, Journal of Biological Chemistry.
[3] H. Stunnenberg,et al. Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008 , 2011, Molecular Cancer Therapeutics.
[4] S. Guan,et al. SIRT6 stabilizes DNA-dependent Protein Kinase at chromatin for DNA double-strand break repair , 2009, Aging.
[5] Eleni P. Mimitou,et al. Nucleases and helicases take center stage in homologous recombination. , 2009, Trends in biochemical sciences.
[6] Tobias Rumpf,et al. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). , 2010, Biochimica et biophysica acta.
[7] S. Tucker,et al. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of γ-H2AX foci , 2006, Molecular Cancer Therapeutics.
[8] Cuk-Seong Kim,et al. SIRT1 deacetylates APE1 and regulates cellular base excision repair , 2009, Nucleic acids research.
[9] S. Kane,et al. Regulation of WRN Protein Cellular Localization and Enzymatic Activities by SIRT1-mediated Deacetylation* , 2008, Journal of Biological Chemistry.
[10] Huichen Wang,et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. , 2005, Cancer research.
[11] M. Namdar,et al. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents , 2010, Proceedings of the National Academy of Sciences.
[12] D. Wigley,et al. CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing. , 2006, Journal of molecular biology.
[13] Junjie Chen,et al. SIRT1 Regulates Autoacetylation and Histone Acetyltransferase Activity of TIP60* , 2010, The Journal of Biological Chemistry.
[14] J. Leith,et al. Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB). , 1985, Radiation research.
[15] Yingli Sun,et al. DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity , 2007, Molecular and Cellular Biology.
[16] M. Nussenzweig,et al. A Backup DNA Repair Pathway Moves to the Forefront , 2007, Cell.
[17] M. Krstic-Demonacos,et al. Sirtuins: Molecular Traffic Lights in the Crossroad of Oxidative Stress, Chromatin Remodeling, and Transcription , 2011, Journal of biomedicine & biotechnology.
[18] Bo Liu,et al. Mitochondrial ROS generation for regulation of autophagic pathways in cancer. , 2011, Biochemical and biophysical research communications.
[19] D. Longley,et al. Identification of an acetylation-dependant Ku70/FLIP complex that regulates FLIP expression and HDAC inhibitor-induced apoptosis , 2012, Cell Death and Differentiation.
[20] I. Stamenkovic,et al. Superoxide anion is a natural inhibitor of FAS‐mediated cell death. , 1996, The EMBO journal.
[21] R. Medema,et al. FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1* , 2004, Journal of Biological Chemistry.
[22] J. Walker,et al. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair , 2001, Nature.
[23] I. Weissman,et al. A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .
[24] F. Vikhanskaya,et al. Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites , 2003, Cell cycle.
[25] J. Whetstine,et al. Histone H3 methylation links DNA damage detection to activation of the Tip60 tumor suppressor , 2009, Nature Cell Biology.
[26] X. Wang,et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. , 2008, Cancer cell.
[27] Thioredoxin in cancer--role of histone deacetylase inhibitors. , 2006 .
[28] J. Parvin,et al. Histone Deacetylases 9 and 10 Are Required for Homologous Recombination* , 2011, The Journal of Biological Chemistry.
[29] T. Lindahl,et al. Quality control by DNA repair. , 1999, Science.
[30] S. Jackson,et al. Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation , 2010, Science.
[31] Jiri Bartek,et al. Human CtIP promotes DNA end resection , 2007, Nature.
[32] G. Damonte,et al. Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells , 2011, PloS one.
[33] J. -. Park,et al. TNF-α-induced ROS production triggering apoptosis is directly linked to Romo1 and Bcl-XL , 2010, Cell Death and Differentiation.
[34] R. Bhatia,et al. Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. , 2012, Blood.
[35] M. Fraga,et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.
[36] S. Elledge,et al. The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.
[37] W. Miller,et al. Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells , 2011, PloS one.
[38] S. Minucci,et al. Histone deacetylases and epigenetic therapies of hematological malignancies. , 2010, Pharmacological research.
[39] Lucia Altucci,et al. Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.
[40] Andrew J. Wilson,et al. Hdac3 is essential for the maintenance of chromatin structure and genome stability. , 2010, Cancer cell.
[41] L. Girard,et al. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide , 2011, British Journal of Cancer.
[42] C. Chen,et al. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. , 2005, International journal of molecular medicine.
[43] M. Wyatt,et al. Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. , 2006, Chemical research in toxicology.
[44] Delin Chen,et al. Deacetylation of p53 modulates its effect on cell growth and apoptosis , 2000, Nature.
[45] P. Atadja,et al. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. , 2006, Molecular pharmacology.
[46] Jorge A. Almenara,et al. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. , 2003, Cancer research.
[47] P. Glazer,et al. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia , 2007, Oncogene.
[48] R. Mantovani,et al. DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines* , 2006, Journal of Biological Chemistry.
[49] Ralph Scully,et al. Role of mammalian Mre11 in classical and alternative non-homologous end joining , 2009, Nature Structural &Molecular Biology.
[50] S. Pervaiz,et al. Assessment of oxidative stress-induced DNA damage by immunoflourescent analysis of 8-oxodG. , 2011, Methods in cell biology.
[51] M Raes,et al. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. , 1994, Free radical biology & medicine.
[52] Claudia P. Miller,et al. Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors , 2011, Journal of biomedicine & biotechnology.
[53] T. Okamoto,et al. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.
[54] C. Bradbury,et al. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors , 2005, Leukemia.
[55] M. Hedayati,et al. Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor , 2010, PloS one.
[56] D. Ferguson,et al. Multiple functions of MRN in end-joining pathways during isotype class switching , 2009, Nature Structural &Molecular Biology.
[57] S. Jackson,et al. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen , 1993, Cell.
[58] Steven S. Foster,et al. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair , 2010, Proceedings of the National Academy of Sciences.
[59] W. Plunkett,et al. Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal. , 2006, Blood.
[60] E. Rogakou,et al. DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.
[61] S. Baylin,et al. Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island , 2008, PLoS genetics.
[62] George Iliakis,et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways , 2006, Nucleic acids research.
[63] Pingfang Liu,et al. Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2006, Cell.
[64] É. Ogier-Denis,et al. Les Nox/Duox : une nouvelle famille de NADPH oxydases , 2006 .
[65] P. Marks,et al. Histone deacetylase inhibitors: molecular mechanisms of action , 2007, Oncogene.
[66] R. Taneja,et al. Oxidative stress regulation of stem and progenitor cells. , 2009, Antioxidants & redox signaling.
[67] L. Magnaghi-Jaulin,et al. Histone deacetylase inhibitors and genomic instability. , 2009, Cancer letters.
[68] William Arbuthnot Sir Lane,et al. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. , 2007, Molecular cell.
[69] S. Iida,et al. Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells , 2007, Leukemia.
[70] S. Jackson,et al. Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4 , 2010, The EMBO journal.
[71] Ralph Scully,et al. Mechanisms of double-strand break repair in somatic mammalian cells. , 2009, The Biochemical journal.
[72] L. Gordon,et al. PCI-24781 Induces Caspase and Reactive Oxygen Species–Dependent Apoptosis Through NF-κB Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells , 2009, Clinical Cancer Research.
[73] G. Mufti,et al. Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis? , 2006, Molecular Cancer Research.
[74] S. Miyamoto. Nuclear initiated NF-κB signaling: NEMO and ATM take center stage , 2011, Cell Research.
[75] Xiaofeng Jiang,et al. The FATC Domains of PIKK Proteins Are Functionally Equivalent and Participate in the Tip60-dependent Activation of DNA-PKcs and ATM* , 2006, Journal of Biological Chemistry.
[76] P. Jeggo,et al. The two edges of the ATM sword: co-operation between repair and checkpoint functions. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[77] L. Altucci,et al. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells , 2005, Nature Medicine.
[78] M. Guenther,et al. Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response , 2003, The Journal of cell biology.
[79] Penny A. Jeggo,et al. The role of double-strand break repair — insights from human genetics , 2006, Nature Reviews Genetics.
[80] P. Dent,et al. Kinase 1 Activation Downregulation, and C-jun N-terminal Mediated by Oxidative Damage, Xiap Leukemia Cells through a Process B Activation Potentiates Apoptosis in Κ Nf- Inhibitor-induced Rela/p65 Acetylation and Blockade of Histone Deacetylase , 2005 .
[81] E. Seto,et al. Lysine acetylation: codified crosstalk with other posttranslational modifications. , 2008, Molecular cell.
[82] C. Deng,et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. , 2010, Cancer cell.
[83] C. Benz,et al. Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes , 2005, Clinical Cancer Research.
[84] I. Christensen,et al. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas , 2009, Histopathology.
[85] R. Salgia,et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. , 1999, Blood.
[86] Xiaofeng Jiang,et al. Tip60: Connecting chromatin to DNA damage signaling , 2010, Cell cycle.
[87] J. Jiricny,et al. Recent progress in the biology, chemistry and structural biology of DNA glycosylases , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[88] J. Nam,et al. Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues. , 2008, Journal of gynecologic oncology.
[89] G. Perez,et al. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. Lübbert,et al. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy , 2010, Clinical Epigenetics.
[91] David J. Chen,et al. The DNA-dependent Protein Kinase Catalytic Activity Regulates DNA End Processing by Means of Ku Entry into DNA* , 1999, The Journal of Biological Chemistry.
[92] D. Roth,et al. Mechanisms of nonhomologous recombination in mammalian cells , 1985, Molecular and cellular biology.
[93] J. McCaul,et al. Sirtuins, Bioageing, and Cancer , 2011, Journal of aging research.
[94] K. Mori,et al. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[95] G. Perez,et al. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor , 2006, Proceedings of the National Academy of Sciences.
[96] D. Roth,et al. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. , 2009, Molecular cell.
[97] P. Calsou,et al. Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. , 2008, Biochemical and biophysical research communications.
[98] David J. Chen,et al. MOF and Histone H4 Acetylation at Lysine 16 Are Critical for DNA Damage Response and Double-Strand Break Repair , 2010, Molecular and Cellular Biology.
[99] J A Hardin,et al. Mechanism of interaction between Ku protein and DNA. , 1986, The Journal of biological chemistry.
[100] J. Bartek,et al. More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance , 2011, Nature Cell Biology.
[101] Ke Gong,et al. CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells. , 2012, The Biochemical journal.
[102] M. Esteller,et al. Epigenetic control of nuclear architecture , 2007, Cellular and Molecular Life Sciences.
[103] Hiroko Yamashita,et al. Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast* , 2005, Breast Cancer Research and Treatment.
[104] T. Misteli,et al. The emerging role of nuclear architecture in DNA repair and genome maintenance , 2009, Nature Reviews Molecular Cell Biology.
[105] S. Tucker,et al. Histone Deacetylase Inhibitors Radiosensitize Human Melanoma Cells by Suppressing DNA Repair Activity , 2005, Clinical Cancer Research.
[106] A. Tomkinson,et al. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. , 2008, Blood.
[107] P. Fisher,et al. Histone Deacetylase Inhibitors Activate NF-κB in Human Leukemia Cells through an ATM/NEMO-related Pathway* , 2010, The Journal of Biological Chemistry.
[108] T. Suda,et al. Regulation of reactive oxygen species in stem cells and cancer stem cells , 2012, Journal of cellular physiology.
[109] S. Park,et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. , 2010, Molecular cell.
[110] K. Caldecott. Mammalian single-strand break repair: mechanisms and links with chromatin. , 2007, DNA repair.
[111] D. Cortez,et al. Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. , 2008, Molecular cell.
[112] J. Jassem,et al. Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer , 2011, Drugs.
[113] Jean Gautier,et al. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells , 2009, Nature Structural &Molecular Biology.
[114] Yoshiharu Kawaguchi,et al. MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.
[115] J. Lamerdin,et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. , 1998, Molecular cell.
[116] Xiaoling Li,et al. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C , 2010, Proceedings of the National Academy of Sciences.
[117] N. Nalabothula,et al. Cancer cells' epigenetic composition and predisposition to histone deacetylase inhibitor sensitization. , 2011, Epigenomics.
[118] Martin Kühne,et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. , 2004, Molecular cell.
[119] D. Reinberg,et al. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. , 2007, Genes & development.
[120] M. Grever,et al. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. , 2006, Cancer research.
[121] S. Payne,et al. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. , 2005, Cancer research.
[122] G. Park,et al. SIRT1 promotes DNA repair activity and deacetylation of Ku70 , 2007, Experimental & Molecular Medicine.
[123] Nita Ahuja,et al. Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. , 2012, Cancer cell.
[124] A. Imbalzano,et al. Mammalian SWI/SNF complexes facilitate DNA double‐strand break repair by promoting γ‐H2AX induction , 2006, The EMBO journal.
[125] S. Grant,et al. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress. , 2004, International journal of oncology.
[126] Kohei Miyazono,et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.
[127] Peter Gwynne,et al. Drug Discovery: 5 , 2002 .
[128] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[129] J. Friedberg,et al. Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo , 2011, Molecular Cancer Therapeutics.
[130] L. Samson,et al. Base excision repair in yeast and mammals. , 2000, Mutation research.
[131] J. Yokota,et al. Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors , 2011, Oncogene.
[132] V. Bohr,et al. Base excision repair of oxidative DNA damage and association with cancer and aging. , 2008, Carcinogenesis.
[133] G. Marshall,et al. The critical role of the class III histone deacetylase SIRT1 in cancer. , 2009, Cancer research.
[134] L. Altucci,et al. ERRATUM: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway , 2005, Nature Medicine.
[135] P. Marks,et al. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. , 2000, Journal of the National Cancer Institute.
[136] S. Jackson,et al. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining , 2010, Nature Structural &Molecular Biology.
[137] I. Rahman,et al. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. , 2004, Biochemical pharmacology.
[138] M. Mann,et al. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.
[139] M. Falzon,et al. EBP-80, a transcription factor closely resembling the human autoantigen Ku, recognizes single- to double-strand transitions in DNA. , 1993, The Journal of biological chemistry.
[140] Arunasree M. Kalle,et al. Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. , 2010, Biochemical and biophysical research communications.
[141] Myriam Gorospe,et al. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase , 2004, Science.
[142] Xiaodan Yu,et al. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells. , 2008, Journal of proteome research.
[143] A. Seluanov,et al. SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.
[144] K. Camphausen,et al. Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275 , 2004, Cancer Research.
[145] M. Kelley,et al. Review of mammalian DNA repair and translational implications. , 2000, The Journal of pharmacology and experimental therapeutics.
[146] Jessica E. Bolden,et al. Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.
[147] S. Pervaiz,et al. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells , 2012, Cell Death and Differentiation.
[148] Jorge A. Almenara,et al. Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions , 2008, Molecular Cancer Therapeutics.
[149] T. Kundu,et al. Reversible acetylation of chromatin: Implication in regulation of gene expression, disease and therapeutics , 2009, Biotechnology journal.
[150] Jianyuan Luo,et al. SIRT1 regulates UV-induced DNA repair through deacetylating XPA. , 2010, Molecular cell.
[151] Z. Herceg,et al. Histone acetylation by Trrap–Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks , 2006, Nature Cell Biology.
[152] A. Sancar,et al. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. , 2004, Annual review of biochemistry.
[153] S. Grant,et al. HDAC Inhibitors Potentiate the Activity of the BCR/ABL Kinase Inhibitor KW-2449 in Imatinib-Sensitive or -Resistant BCR/ABL+ Leukemia Cells In Vitro and In Vivo , 2011, Clinical Cancer Research.
[154] S. Minucci,et al. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.
[155] Paul Van Houtte,et al. NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. , 2006, Cancer letters.
[156] William Arbuthnot Sir Lane,et al. SIRT1 Deacetylates the DNA Methyltransferase 1 (DNMT1) Protein and Alters Its Activities , 2011, Molecular and Cellular Biology.
[157] Yung-Hyun Choi,et al. Sensing of Ionizing Radiation-induced DNA Damage by ATM through Interaction with Histone Deacetylase* , 1999, The Journal of Biological Chemistry.
[158] M. V. Van Dyke,et al. Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. , 2007, Chemistry & biology.
[159] O. Hermanson,et al. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide , 2010, Oncogene.
[160] K. Khanna,et al. DNA double-strand breaks: signaling, repair and the cancer connection , 2001, Nature Genetics.
[161] Y. Yamaoka,et al. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. , 1994, Immunology letters.
[162] Ricky W. Johnstone,et al. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer , 2002, Nature Reviews Drug Discovery.
[163] Andrew W Truman,et al. Epigenetic Modifications in Double-Strand Break DNA Damage Signaling and Repair , 2010, Clinical Cancer Research.
[164] R. Kreienberg,et al. Role of SIRT1 in homologous recombination. , 2010, DNA repair.
[165] W. Weichert,et al. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy , 2008, British Journal of Cancer.
[166] K. Anderson,et al. Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells , 2011, British journal of haematology.
[167] Y. Oda,et al. Expression profile of class I histone deacetylases in human cancer tissues. , 2007, Oncology reports.
[168] P. Dhar,et al. Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair. , 2007, DNA repair.
[169] Stephen P. Jackson,et al. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage , 2005, Nature.
[170] G. Kristiansen,et al. Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma , 2010, Expert opinion on therapeutic targets.
[171] Francis J Giles,et al. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy. , 2008, Cancer letters.
[172] D. Bernhard,et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[173] Ching-Yu Chen,et al. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. , 2007, Cancer research.
[174] M. Kastan,et al. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.
[175] K. Krause,et al. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.
[176] C. Simone,et al. Physical and Functional HAT/HDAC Interplay Regulates Protein Acetylation Balance , 2010, Journal of biomedicine & biotechnology.
[177] Markus Löbrich,et al. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2 , 2009, The EMBO journal.
[178] N. L. La Thangue,et al. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications , 2012, Immunology and cell biology.
[179] A. El-Osta,et al. The Epigenetic Modifier, Valproic Acid, Enhances Radiation Sensitivity , 2006, Epigenetics.
[180] Hidde Ploegh,et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. , 2004, Molecular cell.
[181] George Iliakis,et al. Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[182] L. Altucci,et al. Sirtuins and Disease: The Road Ahead , 2012, Front. Pharmacol..
[183] H. Scher,et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[184] D. Roth,et al. Nonhomologous recombination in mammalian cells: role for short sequence homologies in the joining reaction , 1986, Molecular and cellular biology.
[185] Peng Huang,et al. Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event , 2004, Cancer Chemotherapy and Pharmacology.
[186] Xiaofeng Jiang,et al. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. , 2005, Proceedings of the National Academy of Sciences of the United States of America.